Summary

Forbedring af engraftment af humane inducerede pluripotente stamcelle afledte Kardiomyocytter via en forbigående hæmning af Rho Kinaseaktivitet

Published: July 10, 2019
doi:

Summary

I denne protokol viser og uddyber vi, hvordan man bruger menneskeskabte pluripotente stamceller til differentiering og rensning af kardiomyocytter, og yderligere om, hvordan man kan forbedre sin transplantations effektivitet med Rho-associeret proteinkinasehæmmer forbehandling i en mus myokardieinfarkt model.

Abstract

En afgørende faktor for at forbedre cellulære terapi effektivitet for Myokardie regenerering er at sikkert og effektivt øge cellen engraftment sats. Y-27632 er en meget potent hæmmer af Rho-associeret, coiled-spole-holdige protein kinase (RhoA/ROCK) og bruges til at forhindre dissociation-induceret celle apoptose (anoikis). Vi viser, at Y-27632 forbehandling for menneskeskabte pluripotente stamcelle-afledte kardiomyocytter (hiPSC-CMs+ Ri) forud for implantation resulterer i en celle engraftment rate forbedring i en musemodel af akut MYOKARDIEINFARKT (MI). Her beskriver vi en komplet procedure af hiPSC-CMs differentiering, rensning, og celle forbehandling med Y-27632, samt den resulterende celle sammentrækning, calcium forbigående målinger, og transplantation i mus MI modeller. Den foreslåede metode giver en enkel, sikker, effektiv og billig metode, som i væsentlig grad øger cellengraftment sats. Denne metode kan ikke kun anvendes i forbindelse med andre metoder til yderligere at forbedre celletransplantation effektivitet, men også giver et gunstigt grundlag for studiet af mekanismerne i andre hjertesygdomme.

Introduction

Stamcelle baserede terapier har vist et betydeligt potentiale som en behandling for hjerte skader forårsaget af MI1. Brugen af differentierede hiPSCs giver en uudtømmelig kilde til hiPSC-CMs2 og åbner døren for en hurtig udvikling af banebrydende behandlinger. Men, mange begrænsninger for terapeutisk oversættelse forbliver, herunder udfordringen med den alvorligt lave engraftment sats af implanterede celler.

Dissocierende celler med trypsin initierer anoikis3, som kun accelereres, når disse celler injiceres i barske miljøer som den iskæmiske myokardiet, hvor det hypoxiske miljø accelererer kursen mod celledød. Af de resterende celler, en stor del vaskes ud fra implantationsstedet ind i blodbanen og spredes i hele periferien. En af de vigtigste apoptotiske veje er RhoA/ROCK pathway4. Baseret på tidligere forskning, rhoa/rock pathway regulerer actin cytoskelet organisation5,6, som er ansvarlig for celle dysfunktion7,8. Rock inhibitor Y-27632 er meget udbredt under somatisk og stamcelle dissociation og passaging, at øge celle vedhæftning og reducere celle apoptose9,10,11. I dette studie anvendes Y-27632 til behandling af hiPSC-CMs før transplantation i et forsøg på at øge cellernes engraftment.

Der er fastlagt flere metoder til forbedring af celle engraftment, såsom varmechok og kælder membran matrix belægning12. Bortset fra disse metoder kan genteknologi også fremme kardiomyocyt proliferation13 eller vende nonmyokardial celler til kardiomyocytter14. Fra Bioengineering perspektiv, cardiomyocytter seedet på en biomaterialet stilladset for at forbedre transplantationen effektivitet15. Desværre er de fleste af disse metoder komplicerede og dyre. Tværtimod er den metode, der foreslås her, enkel, omkostningseffektiv og effektiv, og den kan bruges som basal behandling før transplantation, samt i konjugering med andre teknologier.

Protocol

Alle dyreforsøg i denne undersøgelse blev godkendt af den institutionelle dyrepleje-og brugs Komité (IACUC) fra University of Alabama i Birmingham og var baseret på de nationale institutter for sundheds laboratoriets dyrepleje og retningslinjer for anvendelse (NIH publication No 85-23). 1. forberedelse af kultur medier og kultur plader Medium forberedelse For hiPSC medium blandes 400 mL humant pluripotente stamcelle (hPSC) basal medium (tabel o…

Representative Results

Det hipsc-CMS, der anvendes i dette studie, stammer fra menneskelig oprindelse med der reporter-genet; Overlevelsesraten for de transplanterede celler in vivo blev derfor påvist ved bioluminescens Imaging (BLI)17 (figur 1a, B). For histologiske hjerte sektioner blev Human-specifikke kardiale troponin T (hcTnT) og humane nukleare antigen (HNA) dobbelt positive celler klassificeret som enpodet hiPSC-CMs (<strong class="…

Discussion

De vigtigste trin i denne undersøgelse omfatter at opnå ren hiPSC-CMs, forbedre aktiviteten af hiPSC-CMs gennem Y-27632 forbehandling, og endelig, transplantere en præcis mængde hiPSC-CMs i en mus MI model.

De centrale spørgsmål, der blev behandlet her, var, at vi først optimerede de glucosefri rensningsmetoder19 og etablerede et nyt effektivt rensningssystem. System proceduren omfattede anvendelse af celle dissociations enzymer, genbeplantning af celler i gelati…

Divulgazioni

The authors have nothing to disclose.

Acknowledgements

Forfatterne takker Dr. Joseph C. Wu (Stanford University) for venligt at give Fluc-GFP konstruere og Dr. Yanwen Liu for fremragende teknisk assistance. Denne undersøgelse er støttet af National Institutes of Health RO1 tilskud HL95077, HL114120, HL131017, HL138023, UO1 HL134764 (til J.Z.), og HL121206A1 (til L.Z.), og en R56 Grant HL142627 (til W.Z.), en amerikansk hjerte forening videnskabsmand udvikling Grant 16SDG30410018, og University of Alabama på Birmingham Faculty Development Grant (til W.Z.).

Materials

Reagent
Accutase (stem cell detachment solution) STEMCELL Technologies #07920
B27 minus insulin Fisher Scientific A1895601
B27 Supplement Fisher Scientific 17-504-044
CHIR99021 Stem Cell Technologies 72054
DMEM (1x), high glucose, HEPES, no phenol red Thermofisher 20163029
Fetal bovine serum Atlanta Biologicals S11150
Fluo-4 AM (calcium indicator) Invitrogen/Thermofisher F14201
Glucose-free RPMI 1640 Fisher Scientific 11879020
IWR1 Stem Cell Technologies 72562
Matrigel (extracellular matrix ) Fisher Scientific CB-40230C
mTeSR (human pluripotent stem cells medium) STEMCELL Technologies 85850
Pen-strep antibiotic Fisher Scientific 15-140-122
Pluronic F-127 (surfactant polyol) Sigma-Aldrich P2443
Rho activator II Cytoskeleton CN03
RPMI1640 Fisher Scientific 11875119
Sodium DL-lactate Sigma-Aldrich L4263
TrypLE (cell-dissociation enzymes) Fisher Scientific 12-605-010
Verapamil Sigma-Aldrich V4629
Y-27632 STEMCELL Technologies 72304
Name Company Catalog Number Comments
Equipment and Supplies
IVIS Lumina III Bioluminescence Instruments PerkinElmer CLS136334
15 mm Coverslips Warner CS-15R15
Centrifuge Eppendorf 5415R
Confocal Microscope Olympus IX81
Cryostat Thermo Scientific NX50
Dual Automatic Temperature Controller Warner Instruments TC-344B
Electrophoresis Power Supply BIO-RAD 1645050
Fluoresence Microscope Olympus IX83
High Speed Camera pco 1200 s
Laser Scan Head Olympus FV-1000
Low Profile Open Bath Chamber (mounts into above microincubation system) Warner Instruments RC-42LP
Microincubation System Warner Instruments DH-40iL
Minivent Mouse Ventilator Harvard Apparatus 845
NOD/SCID mice Jackson Laboratory 001303
Precast Protein Gels BIO-RAD 4561033
PVDF Transfer Packs BIO-RAD 1704156
Trans-Blot System BIO-RAD Trans-Blot Turbo
Hot bead sterilizer Fine Science Tools 18000-45
Name Company Catalog Number Comments
Antibody
Anti-human Nucleolin (Alexa Fluor 647) Abcam ab198580
Cardiac Troponin T R&D Systems MAB1874
Cardiac Troponin C Abcam ab137130
Cardiac Troponin I Abcam ab47003
Cy5-donkey anti-mouse Jackson ImmunoResearch Laboratory 715-175-150
Cy3-donkey anti-rabbit Jackson ImmunoResearch Laboratory 711-165-152
Fitc-donkey anti-mouse Jackson ImmunoResearch Laboratory 715-095-150
GAPDH Abcam ab22555
Human Cardiac Troponin T Abcam ab91605
Integrin β1 Abcam ab24693
Ki67 EMD Millipore ab9260
N-cadherin Abcam ab18203
Phospho-Myosin Light Chain 2 Cell Signaling Technology 3671s
Name Company Catalog Number Comments
Software
Matlab MathWorks R2016A
Image J NIH 1.52g

Riferimenti

  1. Menasche, P., et al. Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. European Heart Journal. 36 (12), 743-750 (2015).
  2. Burridge, P. W., Keller, G., Gold, J. D., Wu, J. C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell. 10 (1), 16-28 (2012).
  3. Frisch, S. M., Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. Journal of Cell Biology. 124 (4), 619-626 (1994).
  4. Haun, F., et al. Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin. Nature Communications. 9 (1), 3524 (2018).
  5. Ohashi, K., et al. Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. Journal of Biological Chemistry. 275 (5), 3577-3582 (2000).
  6. Katoh, K., Kano, Y., Noda, Y. Rho-associated kinase-dependent contraction of stress fibres and the organization of focal adhesions. Journal of The Royal Society Interface. 8 (56), 305-311 (2011).
  7. Paoli, P., Giannoni, E., Chiarugi, P. Anoikis molecular pathways and its role in cancer progression. Biochimica et Biophysica Acta. 1833 (12), 3481-3498 (2013).
  8. Legate, K. R., Fassler, R. Mechanisms that regulate adaptor binding to beta-integrin cytoplasmic tails. Journal of Cell Science. 122 (Pt 2), 187-198 (2009).
  9. Watanabe, K., et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nature Biotechnology. 25 (6), 681-686 (2007).
  10. Emre, N., et al. The ROCK inhibitor Y-27632 improves recovery of human embryonic stem cells after fluorescence-activated cell sorting with multiple cell surface markers. PLoS One. 5 (8), e12148 (2010).
  11. Ni, Y., Qin, Y., Fang, Z., Zhang, Z. ROCK Inhibitor Y-27632 Promotes Human Retinal Pigment Epithelium Survival by Altering Cellular Biomechanical Properties. Current Molecular Medicine. 17 (9), 637-646 (2017).
  12. Laflamme, M. A., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology. 25 (9), 1015-1024 (2007).
  13. Zhu, W., Zhao, M., Mattapally, S., Chen, S., Zhang, J. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle. Circulation Research. 122 (1), 88-96 (2018).
  14. Song, K., et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature. 485 (7400), 599-604 (2012).
  15. Ye, L., et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell. 15 (6), 750-761 (2014).
  16. Tohyama, S., et al. Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells. Cell Metabolism. 23 (4), 663-674 (2016).
  17. Ong, S. G., et al. Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction. Circulation. 132 (8), 762-771 (2015).
  18. Zhao, M., et al. Y-27632 Preconditioning Enhances Transplantation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Myocardial Infarction Mice. Cardiovascular Research. , (2018).
  19. Tohyama, S., et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell. 12 (1), 127-137 (2013).
  20. Silginer, M., Weller, M., Ziegler, U., Roth, P. Integrin inhibition promotes atypical anoikis in glioma cells. Cell Death & Disease. 5, e1012 (2014).
  21. Lelievre, E. C., et al. N-cadherin mediates neuronal cell survival through Bim down-regulation. PLoS One. 7 (3), e33206 (2012).
  22. Murata, K., et al. Increase in cell motility by carbon ion irradiation via the Rho signaling pathway and its inhibition by the ROCK inhibitor Y-27632 in lung adenocarcinoma A549 cells. Journal of Radiation Research. 55 (4), 658-664 (2014).
  23. Srivastava, K., Shao, B., Bayraktutan, U. PKC-beta exacerbates in vitro brain barrier damage in hyperglycemic settings via regulation of RhoA/Rho-kinase/MLC2 pathway. Journal of Cerebral Blood Flow & Metabolism. 33 (12), 1928-1936 (2013).
check_url/it/59452?article_type=t

Play Video

Citazione di questo articolo
Zhao, M., Tang, Y., Ernst, P. J., Kahn-Krell, A., Fan, C., Pretorius, D., Zhu, H., Lou, X., Zhou, L., Zhang, J., Zhu, W. Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity. J. Vis. Exp. (149), e59452, doi:10.3791/59452 (2019).

View Video